Whipple's disease is a systemic disorder associated with a cultivation-resistant, poorly characterized actinomycete, Tropheryma whippelii. We determined a nearly complete rRNA operon sequence of T. whippelii from specimens from 3 patients with Whipple's disease, as well as partial operon sequences from 43 patients. Variability was observed in the 16S-23S rRNA spacer sequences, leading to the description of five distinct sequence types. One specimen contained two spacer sequence types, raising the possibility of a double infection. Secondary structure models for the primary rRNA transcript and mature rRNAs revealed rare or unique features.Whipple's disease was described in 1907 (as intestinal lipodystrophy) and is a multisystem disorder of humans involving the intestinal tract as well as various other organs (3). A constant feature of the disease is the presence in affected tissues of uniform bacteria that are approximately 0.2 by 1.5 to 2.5 m. These bacteria have a characteristic morphology when viewed with electron microscopy (25). However, numerous attempts to cultivate this bacterium have failed (3). In 1997, propagation in human macrophage cell cultures was reported (24), and recently, propagation in human fibroblasts (20), but these findings have not yet been confirmed by other groups. Thus, this organism remains poorly characterized.Molecular data from the Whipple's disease bacterium became available through broad-range 16S ribosomal DNA (rDNA) PCR and sequence analysis (21, 31). A phylogenetic assessment based on 1,321 bp of 16S rDNA established the bacterium (Tropheryma whippelii) as an actinomycete (21). Taxon-specific 16S rDNA primers have since been used to detected the bacterium in additional patients with Whipple's disease (19,21,28,29), as well as in sewage effluent (16). The determination of a nearly complete 16S rDNA sequence and the 16S-23S ribosomal RNA intergenic spacer sequence has provided additional information (16). A reassessment of its phylogeny revealed a position between the actinomycetes with group B peptidoglycan and the family Cellulomonadaceae.The 16S-23S rDNA spacer has been used for strain differentiation in a variety of bacterial species (4). Two recent studies, both from the same group in Switzerland, addressed the potential variability of the 16S-23S ribosomal intergenic spacer of T. whippelii (5, 6). In the first study, the spacer region was found to be homogenous in specimens from 9 Swiss individuals; in the second study, three types of intergenic spacers were detected in specimens from 28 individuals. In contrast to the 16S-23S rDNA spacer, little information has been published on the intraspecies variability of the 23S-5S rDNA spacer and of regions immediately upstream and downstream of the rRNA operon.